tiprankstipranks
Lucid Diagnostics (LUCD)
NASDAQ:LUCD
US Market

Lucid Diagnostics (LUCD) Similar Stocks

Compare
448 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lucid Diagnostics
$1.58
$137.23M
65.56%
5 Buy
0 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$0.68
$137.40M
-24.44%
5 Buy
2 Hold
1 Sell
Moderate Buy
Greenwich LifeSciences
$10.22
$134.34M
-49.89%
1 Buy
0 Hold
0 Sell
Moderate Buy
EUDA Health Holdings
$3.66
$135.98M
98.91%
0 Buy
0 Hold
0 Sell
Moderate Buy
Lexeo Therapeutics, Inc.
$4.10
$136.11M
-78.11%
4 Buy
0 Hold
0 Sell
Strong Buy
BioAge Labs, Inc.
$3.82
$136.95M
0 Buy
3 Hold
1 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LUCD
Lucid Diagnostics
1.49
0.60
67.42%
NKTR
Nektar Therapeutics
0.68
-0.27
-28.42%
GLSI
Greenwich LifeSciences
9.54
-7.95
-45.45%
EUDA
EUDA Health Holdings
3.64
1.80
97.83%
LXEO
Lexeo Therapeutics, Inc.
3.47
-11.13
-76.23%
BIOA
BioAge Labs, Inc.
3.76
-17.24
-82.10%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis